These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6182409)

  • 1. Comparison of [3H]bepridil and [3H]verapamil uptake into rabbit aortic rings.
    Mras S; Sperelakis N
    J Cardiovasc Pharmacol; 1982; 4(5):777-83. PubMed ID: 6182409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bepridil (CERM-1978) an verapamil depression of contractions of rabbit aortic rings.
    Mras S; Sperelakis N
    Blood Vessels; 1981; 18(4-5):196-205. PubMed ID: 6975144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
    Galizzi JP; Fosset M; Lazdunski M
    Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bepridil hydrochloride alters potential-dependent and receptor-operated calcium channels in vascular smooth muscle of rabbit aorta.
    Flaim SF; Ratz PH; Swigart SC; Gleason MM
    J Pharmacol Exp Ther; 1985 Jul; 234(1):63-71. PubMed ID: 2409274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bepridil compared with calcium antagonists on rat and rabbit aorta.
    Winslow E; Farmer S; Martorana M; Marshall RJ
    Eur J Pharmacol; 1986 Nov; 131(2-3):219-28. PubMed ID: 3493158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of the calcium channel blocker, bepridil, to calmodulin.
    Itoh H; Tanaka T; Mitani Y; Hidaka H
    Biochem Pharmacol; 1986 Jan; 35(2):217-20. PubMed ID: 3484629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of bepridil and verapamil on isolated coronary and systemic vascular and cardiac muscle.
    Campbell JK; Marshall RJ; Winslow E
    Eur J Pharmacol; 1982 Dec; 86(2):217-28. PubMed ID: 6984392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology of calcium inhibitors].
    Singlas E; Martre H; Taburet AM
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.
    Galizzi JP; Fosset M; Romey G; Laduron P; Lazdunski M
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7513-7. PubMed ID: 2429309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bepridil blockade of Ca2+-dependent action potentials in vascular smooth muscle of dog coronary artery.
    Harder DR; Sperelakis N
    J Cardiovasc Pharmacol; 1981; 3(4):906-14. PubMed ID: 6167820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium antagonists on release of [3H]noradrenaline in rabbit aorta.
    Karaki H; Nakagawa H; Urakawa N
    Eur J Pharmacol; 1984 Jun; 101(3-4):177-83. PubMed ID: 6468494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
    Kato R; Singh BN
    Am Heart J; 1986 Feb; 111(2):271-9. PubMed ID: 3484892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromechanical effects of bepridil on rabbit isolated hearts.
    Anno T; Furuta T; Itoh M; Kodama I; Toyama J; Yamada K
    Br J Pharmacol; 1984 Jan; 81(1):41-7. PubMed ID: 6608388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.